Nature Medicine, Published online: 10 January 2025; doi:10.1038/s41591-024-03463-zIn a crossover trial evaluating semaglutide versus placebo as an add-on to automated
Nature Medicine, Published online: 10 January 2025; doi:10.1038/s41591-024-03343-6National modeling estimates reported that three million children experience orphanhood and caregiver loss
Ouro will leverage $120 million in funding to develop novel T cell engagers with potential to reset the immune system
NEW YORK, Jan. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the
Two-day symposium in Riyadh, Saudi Arabia brings together leading oncology professionals from across the MENA region to review updated treatment
SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing
BERLIN, Jan. 10, 2025 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and
As a leading Central Public Sector Enterprise, SECI plays a pivotal role in the development and expansion of Renewable Energy
Profit before tax (PBT) for the quarter stood at ₹538.20 crore, up 39.38% from ₹386.14 crore in Q3 FY24. Profit